Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04231968 |
| Consolidated Lead Sponsor | Shanghai Ark Biopharmaceutical Co |
| Therapeutic Condition Cohort | Infectious Disease and Vaccines |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 311 participants (ACTUAL) |
| Registered Start Date | 2020-09-22 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Peking University Third Hospital | Beijing, China | Open Hospital Dossier -> |
| The First Bethune Hospital of Jilin University | Changchun, China | Open Hospital Dossier -> |
| Liaocheng People's hospital | Liaocheng, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.